以中医神志学说辨析百合病

运用神魂魄意志五神与五藏、五官、五体的配属关系．结合文献对百合病命名、病位、症状、病机及愈期判断加以探讨。提出百合病属中医神志失和类病变，由热病伤阴，余邪未尽．心肺阴虚，神志失养，加之情怀不畅，气郁不舒，百脉失调，形神失和而发病。     

常规医疗设备招标存在问题的思考和对策--决策学多属性效用理论的实践探索

通过对常规医疗设备招标存在问题的思考,采用决策学多属性效用理论作为一种对策方法,并在实际操作中进行了尝试探索,以取得更好的效果.     

和谐教学的基本原理

本文作者密切联系构建和谐社会的理论与实践，科学地探讨了教学过程自身的和谐、教学过程与教学环境的和谐等实践问题。     

信息超载现象的传播效果分析及其解决对策

文章从传播效果的角度详尽分析了多媒体教学和网络教学中的信息超载现象,并提出相应的解决对策。     

用科学理论指导"五四一"医院经营管理模式的研究

本文介绍了广东省第二人民医院,用科学理论指导"五四一"医院经营管理模式研究的改革实践.分别阐述了"五四一"医院经营管理模式的研究基础、方向和核心目标.     

Heart health inequalities in Canada: modules, theory and planning

It is well known that prevalence and incidence rates of cardiovasculardisease (CVD) and CVD risk factors are not equally distributedamong socioeconomic groups. Known risk factors account for part,but not all of unequally distributed CVD rates. Socioeconomicconditions and psychosocial dynamics may explain another pareof the increased CVD rates. Theoretically, it may be possibleto lower CVD rates and CVD risk factor prevalence among lowersocioeconomic status (SES) groups by using a community development(socio-environment) strategy directed towards changes in socioenvrronmentalrisk conditions and psychosocial risk factors, rather than CVDrisk factors per Se. This article describes a protocol for sucha strategy based upon the planning work of Canadian health professionals,loosely organized under a project titled ‘Heart HealthInequalities in Canada’ This protocol incorporates baselinedata on CVD and CVD risk factor prevalence, but is premisedon actions negotiated between community organizations and healthauthorities, rather than defined unilaterally by health authorities.As such, program design activities and evaluation will differfrom a more general population-based risk factor reduction strategy.     

运用现代教育理论思想 提高医学课堂教学质量

本文依据三种现代教育理论思想的有益启示,围绕医学高等专科学校课堂教学质量的提升问题,提出以加强教育理论思想研修为突破口,进而采取更新教育观念、狠抓移植应用和改进教法学法来有效提高医学高等专科学校课堂教学质量的新思路。     

Adaptive group sequential design for phase II clinical trials: A Bayesian decision theoretic approach

Bayesian decision theoretic approaches (BDTAs) have been widely studied in the literature as tools for designing and conducting phase II clinical trials. However, full Bayesian approaches that consider multiple endpoints are lacking. Since the monitoring of toxicity is a major goal of phase II trials, we propose an adaptive group sequential design using a BDTA, which characterizes efficacy and toxicity as correlated bivariate binary endpoints. We allow trade‐off between the two endpoints. Interim evaluations are conducted group sequentially, but the number of interim looks and the size of each group are chosen adaptively based on current observations. We utilize a loss function consisting of two components: the loss associated with accruing, treating, and monitoring patients, and the loss associated with making incorrect decisions. The performance of our Bayesian modeling, and the operating characteristics of decision rules under a wide range of loss function parameters are evaluated using seven scenarios in a simulation study. Our method is illustrated in the context of a single‐arm phase II trial of bevacizumab, gemcitabine, and oxaliplatin in patients with metastatic pancreatic adenocarcinoma. Copyright © 2009 John Wiley & Sons, Ltd.